Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 1,407 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: Obesity, Heart Failure, Diastolic, Metabolic Syndrome
Interventions: High intensity exercise, Omega-3 fish oil, Yoga, olive oil capsules; Behavioral · Dietary Supplement
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 40 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Severe Stroke or Similar Neurological Muscle Weakness
Interventions: Ekso exoskeleton; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Myocardial Infarction, Myocardial Infarction, Acute, Myocardial Infarction Old
Interventions: BioMonitor; Device
Lead sponsor: Biotronik SE & Co. KG; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 802 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 8
States / cities: St Louis, Missouri • Rochester, New York • Grand Forks, North Dakota + 4 more

Conditions: Spinal Cord Injuries
Interventions: Muscle strengthening exercise followed by Hybrid FES cycling Exercise, Active ROM exercise with arms and Passive ROM exercise with legs; Other
Lead sponsor: William Carey University; Other
Eligibility: 21 Years to 70 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Hattiesburg, Mississippi

Conditions: Stroke, Hemiparesis
Interventions: Multichannel Functional electrical stimulation, Standard motor training; Device · Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Frisco, Texas

Conditions: Stroke
Interventions: Ischemic Conditioning; Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Milwaukee, Wisconsin

Conditions: Stroke, Sleep Wake Disorders, Rehabilitation, Recovery of Function
Interventions: Observation; Other
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Atlanta, Georgia • Kansas City, Kansas • Syracuse, New York + 1 more

Conditions: Systemic Lupus Erythematosus, Cardiovascular Disease, Premature Atherosclerosis
Interventions: anifrolumab, Placebo; Drug · Other
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke, Post-Stroke Hemiparesis
Interventions: Gravity Elimination Alone, Path Assistance Alone, Path Assistance and Gravity Elimination; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Atherosclerosis, Endothelial Function
Interventions: Nebivolol, Atenolol; Drug
Lead sponsor: Emory University; Other
Eligibility: 21 Years to 79 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hypercholesterolemia, Hypertension
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Analgesia, Obstetrical, Coagulation Defect; Postpartum, Nonsteroidals (NSAIDs)Toxicity, Postpartum Hemorrhage, Postoperative Pain, Ketorolac Adverse Reaction, Blood Loss, Postoperative
Interventions: Ketorolac Tromethamine 30 MG/ML, Placebos; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coagulation, Platelet Function
Interventions: Not listed
Lead sponsor: Haemonetics Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Baltimore, Maryland • Knoxville, Tennessee

Conditions: Multiple Myeloma
Interventions: Cyclophosphamide, Ciltacabtagene Autoleucel, Total body irradiation; Drug · Radiation
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cardiovascular Diseases, Hypertension, Racism, Vascular Diseases
Interventions: MitoQ; Dietary Supplement
Lead sponsor: Auburn University; Other
Eligibility: 45 Years to 75 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Hypothalamic Amenorrhea
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Stroke, Acute, Stroke, Hemiparesis
Interventions: NMES device with EMG-triggered and Cyclic capabilities; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years to 89 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 3
States / cities: Akron, Ohio • Cincinnati, Ohio • Cleveland, Ohio

Conditions: Cerebrovascular Accident
Interventions: Active transcranial Direct Current Stimulation / Constraint Induced Movement Therapy, Sham transcranial Direct Current Stimulation / Constraint Induced Movement Therapy; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Disease
Interventions: Control, Peanut; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 20 Years to 50 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Pulmonary Disease, Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Inflammation, Pathologic Processes
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiomyopathy, Dilated, Cardiomyopathy, Hypertrophic, Insulin Resistance
Interventions: Oral glucose tolerance test; Diagnostic Test
Lead sponsor: Le Bonheur Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: High Blood Pressure, Liver Transplant, Renal Function Abnormal
Interventions: Amlodipine Besylate, Chlorthalidone; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Peripheral Arterial Disease, Intermittent Claudication
Interventions: Exercise training, NMES; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 80 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Improving Metabolic Health in Patients With Diastolic Dysfunction

Mobility Training Using Exoskeletons for Functional Recovery After Stroke

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction

Hybrid HIIT-FES Cycling Program on Individuals With Spinal Cord Injury to Improve Health

Effectiveness of Multichannel Functional Electrical Stimulation

Blood Flow Regulation and Neuromuscular Function Post-Stroke

The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

Evaluation of a Wearable Exoskeleton for Functional Arm Training

Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques

Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol

IV Ketorolac on Platelet Function Post-Cesarean Delivery

RapidTEG MA Validation

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Mitochondria Oxidative Stress and Vascular Health Study

Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)

Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke

tDCS and Physical Therapy in Stroke

The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy

Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)

Exercise Rehabilitation in Veterans With PAD